Prior to the high-volume LP, Mr. M was carefully evaluated for gait, cognition, and memory. Then between 30 and 50 ml of CSF was removed and he was reevaluated several hours later using the same ...
In this Innovation Spotlight, Dan Levangie, president and chief executive officer of CereVasc, discusses a new treatment strategy for NPH using an endovascularly implantable CSF shunt that minimizes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback